Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F7TEX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,405
Award facts
- Contract value 100% obligated
- $5,404.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $5,404.53 delivery order to Amerisourcebergen Drug Corp on July 11, 2026, for Dupixent 300 mg/2 ml syringes. The order is a firm fixed-price call against a DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to the Department of Defense and federal healthcare systems.
Place of performance is Conshohocken, PA. The ultimate completion date is July 13, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26F7TEX?
SPE2DR26F7TEX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 11, 2026.
How much is contract SPE2DR26F7TEX worth?
The government has obligated $5,405 on SPE2DR26F7TEX.
Is contract SPE2DR26F7TEX an order under another contract?
Yes. SPE2DR26F7TEX is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7TEX competed?
The extent of competition for SPE2DR26F7TEX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award